Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22,683 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison between the first-line and second-line immunotherapy drugs in the progression-free survival and overall survival in advanced non-small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials.
Wu S, Wang L, Li W, Chen B, Liu Y, Wang H, Zhao S, Ye L, Sun H, He Y. Wu S, et al. Among authors: zhao s. Ann Palliat Med. 2021 Feb;10(2):1717-1726. doi: 10.21037/apm-20-449. Epub 2020 Dec 8. Ann Palliat Med. 2021. PMID: 33302640 Free article.
Clinical features of Bim deletion polymorphism and its relation with crizotinib primary resistance in Chinese patients with ALK/ROS1 fusion-positive non-small cell lung cancer.
Zhang L, Jiang T, Li X, Wang Y, Zhao C, Zhao S, Xi L, Zhang S, Liu X, Jia Y, Yang H, Shi J, Su C, Ren S, Zhou C. Zhang L, et al. Among authors: zhao c, zhao s. Cancer. 2017 Aug 1;123(15):2927-2935. doi: 10.1002/cncr.30677. Epub 2017 Mar 27. Cancer. 2017. PMID: 28346673 Free article.
Characterization of distinct types of KRAS mutation and its impact on first-line platinum-based chemotherapy in Chinese patients with advanced non-small cell lung cancer.
Jia Y, Jiang T, Li X, Zhao C, Zhang L, Zhao S, Liu X, Qiao M, Luo J, Shi J, Yang H, Wang Y, Xi L, Zhang S, Gao G, Su C, Ren S, Zhou C. Jia Y, et al. Among authors: zhao c, zhao s. Oncol Lett. 2017 Dec;14(6):6525-6532. doi: 10.3892/ol.2017.7016. Epub 2017 Sep 21. Oncol Lett. 2017. PMID: 29163686 Free PMC article.
sLAG-3 in non-small-cell lung cancer patients' serum.
He Y, Wang Y, Zhao S, Zhao C, Zhou C, Hirsch FR. He Y, et al. Among authors: zhao s, zhao c. Onco Targets Ther. 2018 Aug 13;11:4781-4784. doi: 10.2147/OTT.S164178. eCollection 2018. Onco Targets Ther. 2018. PMID: 30147330 Free PMC article.
Impact of serum vascular endothelial growth factor and interleukin-6 on treatment response to epidermal growth factor receptor tyrosine kinase inhibitors in patients with non-small-cell lung cancer.
Jia Y, Li X, Zhao C, Jiang T, Zhao S, Zhang L, Liu X, Shi J, Qiao M, Luo J, Liu S, Han R, Chen X, Zhou C. Jia Y, et al. Among authors: zhao c, zhao s. Lung Cancer. 2018 Nov;125:22-28. doi: 10.1016/j.lungcan.2018.08.025. Epub 2018 Aug 31. Lung Cancer. 2018. PMID: 30429024
22,683 results
You have reached the last available page of results. Please see the User Guide for more information.